T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| 1 |
Biogen
BIIB
|
$968M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$576M |
| 3 |
Canadian Natural Resources
CNQ
|
$535M |
| 4 |
CAVA Group
CAVA
|
$519M |
| 5 |
Goldman Sachs
GS
|
$518M |
Top Sells
| 1 |
PNC Financial Services
PNC
|
$757M |
| 2 |
TransUnion
TRU
|
$681M |
| 3 |
Microsoft
MSFT
|
$665M |
| 4 |
Fortinet
FTNT
|
$572M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
$467M |
Sector Composition
| 1 | Technology | 24.37% |
| 2 | Healthcare | 22.65% |
| 3 | Consumer Discretionary | 12.28% |
| 4 | Financials | 11.97% |
| 5 | Industrials | 11.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Metropolitan Bank Holding Corp
MCB
$828M
| $33.5M | 0.02% |
965,572
+48,601
| +5% | +$1.69M |
|
427
nCino
NCNO
$3.52B
| $33.2M | 0.02% |
1,101,707
-481,047
| -30% | -$14.5M |
|
428
Savers
SVV
$1.96B
| $33.2M | 0.02% |
+1,400,000
| New | +$33.2M |
|
429
Equity Bancshares
EQBK
$811M
| $32.7M | 0.02% |
1,437,076
+70,271
| +5% | +$1.6M |
|
430
Artesian Resources
ARTNA
$343M
| $32.4M | 0.02% |
685,863
+266,297
| +63% | +$12.6M |
|
|
JBGS
431
JBG SMITH
JBGS
$1.4B
| $32.3M | 0.02% |
2,148,438
-4,734,311
| -69% | -$71.2M |
|
432
Five Star Bancorp
FSBC
$702M
| $32.2M | 0.02% |
1,438,997
+28,367
| +2% | +$635K |
|
433
Utah Medical Products
UTMD
$203M
| $31.8M | 0.02% |
341,118
-8,722
| -2% | -$813K |
|
|
UMH
434
UMH Properties
UMH
$1.29B
| $31.6M | 0.02% |
1,978,263
+1,031,437
| +109% | +$16.5M |
|
435
John Marshall Bancorp
JMSB
$285M
| $31M | 0.02% |
1,541,260
+91,639
| +6% | +$1.84M |
|
436
Coastal Financial
CCB
$1.66B
| $30.9M | 0.02% |
821,686
+51,895
| +7% | +$1.95M |
|
437
Equity Lifestyle Properties
ELS
$12B
| $30.1M | 0.02% |
449,562
+30,751
| +7% | +$2.06M |
|
438
Ventyx Biosciences
VTYX
$180M
| $29.8M | 0.02% |
909,722
+345,086
| +61% | +$11.3M |
|
439
Watsco
WSO
$16.6B
| $29.6M | 0.02% |
77,639
-2,081
| -3% | -$794K |
|
440
FS Bancorp
FSBW
$321M
| $29.3M | 0.02% |
976,013
+107,295
| +12% | +$3.23M |
|
441
MacroGenics
MGNX
$126M
| $29.2M | 0.02% |
5,462,652
+2,549,247
| +88% | +$13.6M |
|
442
Darling Ingredients
DAR
$5.07B
| $29M | 0.02% |
453,970
-12,897
| -3% | -$823K |
|
443
Relay Therapeutics
RLAY
$710M
| $28.4M | 0.02% |
2,263,360
+41,780
| +2% | +$525K |
|
444
Vail Resorts
MTN
$5.87B
| $28.2M | 0.02% |
111,945
-1,008,590
| -90% | -$254M |
|
445
Matsons
MATX
$3.36B
| $27.9M | 0.02% |
358,344
+12,255
| +4% | +$953K |
|
446
Blue Foundry Bancorp
BLFY
$204M
| $27.7M | 0.02% |
2,742,120
-14,227
| -0.5% | -$144K |
|
447
Blue Bird Corp
BLBD
$1.87B
| $27.7M | 0.02% |
1,230,129
-207,403
| -14% | -$4.66M |
|
448
Gibraltar Industries
ROCK
$1.82B
| $27.5M | 0.02% |
436,510
-315,121
| -42% | -$19.8M |
|
449
Structure Therapeutics
GPCR
$1.27B
| $27.2M | 0.02% |
654,516
+56,408
| +9% | +$2.34M |
|
|
HCP
450
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $27.1M | 0.02% |
1,035,025
+330
| +0% | +$8.64K |
|